logo

For the Inventor, By the Inventor

Bulleen, Australia

Peter J Hudson

This inventor holds 8 USPTO granted patents. Top assignee: Howard Florey Institute of Experimental Physiology and Medicine. Active years: 1988-1994.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Peter J Hudson. Retrieved from https://idiyas.com/inventor/peter-j-hudson

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 100.0

Average Co-Inventor Count = 3.4

ph-index = 7

Forward Citations = 111(Granted Patents)


Location History:

  • Victoria, AU (1993)
  • Bulleen, AU (1988 - 1994)

Company Filing History:

goldMedal8 out of 21 
 
Howard Florey Institute of Experimental Physiology and Medicine
 patents

Years Active: 1988-1994

Loading Chart...
8 patents (USPTO):Explore Patents
1. 5326694 - Process for synthesizing human H2-prorelaxin, human H2-relaxin and (1994-07-05),
2. 5320953 - Process for synthesizing human H1-prorelaxin, H1-relaxin and fusion (1994-06-14),
3. 5179195 - Human relaxin polypeptides (1993-01-12),
4. 5145962 - Human pro relaxin polypeptides (1992-09-08),
5. 5053488 - Molecular cloning and characterization of a gene sequence coding for (1991-10-01),
6. 5023321 - Molecular cloning and characterization of a further gene sequence coding (1991-06-11),
7. 4871670 - Molecular cloning and characterization of a gene sequence coding for (1989-10-03),
8. 4758516 - Molecular cloning and characterization of a further gene sequence coding (1988-07-19),

Title: The Innovations of Peter J Hudson: A Pioneer in Relaxin Research

Introduction: Peter J Hudson, a prominent inventor based in Bulleen, Australia, has made significant contributions to the field of biochemistry and physiology through his innovative research. With a total of eight patents, his work focuses primarily on the synthesis of relaxin peptides and DNA transfer vectors, essential for understanding and developing medical therapies.

Latest Patents: Among Peter J Hudson’s latest innovations are patents related to the synthesis of human H2-prorelaxin and human H2-relaxin. These patents also include genes and DNA transfer vectors for expressing human preprorelaxin, as well as its subunits and peptide chains. He has pioneered methods involving recombinant DNA techniques for synthesizing these peptides. Additionally, his patents encompass a similar process for human H1-prorelaxin and H1-relaxin, highlighting his extensive work in this specialized area of biomedical research.

Career Highlights: Peter J Hudson's career is marked by his tenure at the Howard Florey Institute of Experimental Physiology and Medicine, where he engages in groundbreaking research. His dedication to the field has not only earned him patents but also a reputation as a leading figure in the study of relaxin and its associated peptides.

Collaborations: Throughout his career, Peter has collaborated with esteemed colleagues, including Geoffrey W Tregear and Hugh D Niall. These partnerships have fostered a rich environment for innovation and have contributed significantly to the advancements in peptide synthesis and therapeutic potential.

Conclusion: Peter J Hudson stands out as a key figure in the realm of innovations centered on relaxin research. His contributions, encapsulated in his multiple patents, continue to influence medical research and therapeutic applications. Through his ongoing work and collaborations, he is poised to make even more significant strides in the scientific community.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…